Market Access

Argentina Roadmap
A roadmap to health system efficiency?
Image: G. Novick presentation

In today’s post, Eugenia de la Fuente of GLOBALHealthPR Argentina partner Paradigma PEL Comunicación explains why Argentina needs a uniform health technology assessment process – and why the media should take notice of the issue.

 

[Read more…] about Dilemmas Over the Approval and Delivery of New Health Technologies in a Fragmented and Inefficient System

The ACIAPO Foundation of Argentina, together with other patient associations in the region, inquired into the major difficulties encountered by affected people after they receive their diagnoses. The most frequent ones: bureaucracy and exceedingly long waiting times. GLOBALHealthPR Argentina partner Paradigma explains.

[Read more…] about Barriers to Cancer Treatment Access in Latin America

Prime-Minister-John-Curtin-in-London1_7815338_tcm11-18299
Prime Minister John Curtin, who devised the first PBS in Australia during World War II.

Today’s post comes to us from Mark Henderson of GLOBALHealthPR Australia Partner, VIVA! Communications.

The Pharmaceutical Benefits Scheme, or PBS, is a programme administered by the Australian Government to provide patients with heavily subsidised access to a broad range of prescription medicines. Despite its expansion over the years, access to treatments for some rare disorders under the PBS remains elusive today. [Read more…] about Unravelling Australia’s Pharmaceutical Benefits Scheme

Whether we’re talking about a family, business or country, significant growth inevitably causes a ripple effect of change and requires careful management to keep the proverbial engines running smoothly. As we’ve seen with Google and Apple, properly managed growth can elevate a business to empire status.

Within a decade, China will have the world’s largest economy. As its economy grows, cultural, labor and population trends are shifting. The “Chinese dream” is evolving to resemble the “American dream” as citizens increasingly strive to improve their quality of life. Young adults are going to college instead of working in factories and an emerging middle class works towards home ownership and material wealth.

China’s gradual cultural shift from collectivistic to individualistic is incongruent with its authoritarian government system. Can China maintain a sustainable, healthy business community with existing, limiting government regulation? My guess is no. Will the Chinese government continue to reevaluate its traditional ideals and adjust regulation to nurture its version of the industrial revolution? I hope so.

How is this impacting China’s health care system?

fgb [Read more…] about China’s Economic Growth is a Catalyst for Change in the Country’s Health Care System

1When does your employer pay you for your toil? For the Brits reading this post it is likely to be the 25th of each month; I’ve been paid on this day since my first post-graduation job as a research microbiologist in 1995. Non-UK resident readers will have a different nationally recognised date. In Germany it is the 30th and in Portugal it can be any day between 1st to the 8th of the month. Our U.S. friends often get paid weekly; imagine that monthly paid folk! Think about how that would change the way you manage your money such as deciding when to pay the mortgage. If you have a regular pay structure, you can manage your finances with a degree of confidence.

Uncertainty around when, how or even if things are paid is never a good thing, especially if you are investing heavily and not seeing your return for years to come. This is exactly how global pharmaceutical businesses find themselves when faced with the UK and a future scheme called value-based pricing (VBP).

 

[Read more…] about UK and value-based medicine pricing: Pay day cannot come too soon